Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The firm offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
Follow-Up Questions
Who is the CEO of Lifeward Ltd?
Mr. Mark Grant is the President of Lifeward Ltd, joining the firm since 2025.
What is the price performance of LFWD stock?
The current price of LFWD is $0.5561, it has increased 0.46% in the last trading day.
What are the primary business themes or industries for Lifeward Ltd?
Lifeward Ltd belongs to Health Care industry and the sector is Health Care
What is Lifeward Ltd market cap?
Lifeward Ltd's current market cap is $8.7M
Is Lifeward Ltd a buy, sell, or hold?
According to wall street analysts, 4 analysts have made analyst ratings for Lifeward Ltd, including 2 strong buy, 5 buy, 1 hold, 0 sell, and 2 strong sell
